Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

NCT03415282 is registered in ClinicalTrials.gov with Dermavant Sciences GmbH as lead sponsor.

NCT NCT03415282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Lead sponsor
Dermavant Sciences GmbH
Phase
Phase 1
Overall status
Unknown status
Start date
February 5, 2018
Completion date
August 7, 2018
Enrollment
24 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis